Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 41.92B | 54.15B | 39.57B | 29.56B | 12.00B |
Gross Profit | 10.40B | 8.31B | 7.17B | 5.54B | 3.35B |
EBITDA | 7.70B | 6.12B | 4.54B | 11.47B | -4.64B |
Net Income | 4.39B | 3.45B | 2.44B | 10.36B | -7.65B |
Balance Sheet | |||||
Total Assets | 105.78B | 75.70B | 48.35B | 29.80B | 40.85B |
Cash, Cash Equivalents and Short-Term Investments | 60.71B | 63.64B | 35.58B | 20.30B | 9.25B |
Total Debt | 72.40B | 48.90B | 23.21B | 15.12B | 37.33B |
Total Liabilities | 80.60B | 54.59B | 30.58B | 16.64B | 38.47B |
Stockholders Equity | 25.17B | 21.11B | 17.78B | 13.16B | 2.38B |
Cash Flow | |||||
Free Cash Flow | -26.51B | -26.69B | -4.54B | -814.00M | 2.74B |
Operating Cash Flow | -26.51B | -26.65B | 3.71B | -772.00M | 2.75B |
Investing Cash Flow | -123.00M | -189.00M | -8.43B | 26.08B | 7.79B |
Financing Cash Flow | 22.93B | 25.62B | 9.94B | -22.20B | -11.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥28.11B | 7.82 | 4.09% | 17.40% | 17.97% | ||
76 Outperform | ¥115.04B | 9.21 | 2.73% | 8.56% | 16.30% | ||
74 Outperform | ¥853.12B | 9.95 | 3.57% | 1.67% | 18.46% | ||
71 Outperform | ¥10.42B | 8.14 | 4.16% | 6.95% | 4.92% | ||
70 Outperform | ¥38.90B | 7.50 | 2.25% | 14.18% | 45.35% | ||
70 Outperform | ¥366.84B | 8.07 | 7.42% | -3.25% | 1.65% | ||
67 Neutral | £2.85B | 10.49 | 4.46% | 3.55% | 2.44% | -20.00% |